DalsnaFinance › IPOs › Kiniksa Pharmaceuticals International › IPO
Kiniksa Pharmaceuticals International, plc completed its initial public offering on NASDAQ on May 24, 2018, pricing at $18.00 a share.
| Ticker | KNSA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 24, 2018 |
| Offering price | $18.00 |
| Shares offered | 8,477,777 |
| Total raised | $153M |
Kiniksa Pharmaceuticals International, plc sold 8,477,777 shares at $18.00 each on NASDAQ. Multiplied out, that is $152.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $153 million total recorded for the deal.
Kiniksa Pharmaceuticals International, plc — quote, profile and latest news →
Source: SEC EDGAR filings for Kiniksa Pharmaceuticals International, plc. This page is general information, not investment advice.